Molecular Mechanisms of Sphingolipid Transport on Plasma Lipoproteins

Adv Exp Med Biol. 2022:1372:57-65. doi: 10.1007/978-981-19-0394-6_5.

Abstract

Sphingolipids are biomolecules with diverse physiological functions in signaling as well as plasma membrane structure. They are associated with either cellular membranes or plasma lipoproteins and any changes in their levels may contribute to certain metabolic diseases. Sphingolipids are evenly distributed in lipoproteins and may be used as prognostic and diagnostic markers. Mechanisms involved in the transport of sphingolipids have been recently explored and here we discuss the most recent advances in the molecular mechanisms of sphingolipids transport by lipoproteins. It has been shown that microsomal triglyceride transfer protein (MTP) and ATP-binding cassette transporter family A protein 1 (ABCA1) play an important role in plasma sphingolipid homeostasis. However, the exact mechanisms are not well known. Though much research has already been done to emphasize the impact of sphingolipids changes in many pathological disorders, understanding mechanisms by which circulating lipoproteins assist in transporting sphingolipids may provide novel information that may help in devising strategies to therapeutically target these pathways to treat various metabolic disorders.

Keywords: ABCA1; Abetalipoproteinemia; Ceramides; Hexosylceramides; Lipoproteins; MTP; Sphingolipids; Sphingomyelin; Sphingosine-1-phosphate; Tangier disease.

MeSH terms

  • Ceramides / metabolism
  • Homeostasis
  • Humans
  • Lipoproteins
  • Metabolic Diseases*
  • Sphingolipids* / metabolism

Substances

  • Ceramides
  • Lipoproteins
  • Sphingolipids